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Abstract
Contrast-enhanced endoscopic ultrasound (CE-EUS) represents a new technique that can be used in conjunction with
radial or linear EUS scopes, coupled with the corresponding ultrasound system. The technique is based on a second-
generation blood-pool ultrasound contrast agent injected through a peripheral vein, which subsequently can be visualized
through the microcirculation in the early arterial and late venous phase, especially when used with contrast harmonic
imaging techniques (low mechanical index techniques). Contrast agents can be used as a Doppler signal enhancer (high
mechanical index techniques), although this technique is particularly prone to artifacts. Both techniques can be used in
conjunction with 3D acquisition modes, in order to quantify the vascularity of tumors or to better delineate the rela-
tionship with surrounding vessels. The CE-EUS techniques have been used mostly for pancreatic examinations, i.e., for the
differential diagnosis of focal pancreatic masses. Thus, pancreatic adenocarcinoma has a hypovascular (hypoenhanced)
appearance, whereas neuroendocrine tumors are usually hypervascular (hyperenhanced). Also, pseudotumoral chronic
pancreatitis and autoimmune pancreatitis have an iso- or hypervascular appearance. All these techniques are described in
the present article, with emphasis on the examination modes and technical details. This article is part of an expert video
encyclopedia.
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Video Related to this Article
Materials
• Endoscope: Pentax UTK 3870 linear echoendoscope, Pen-
tax Europe GmbH, Hamburg, Germany.
• Ultrasound: Hitachi HI-VISION Preirus with contrast har-
monic imaging (CHI) and 3D modules, Hitachi Medical
Systems Europe, Zug, Switzerland.
• Contrast: Sono-Vue 4.8 ml/vial, Bracco, Milan, Italy.
Technique
Endoscopic ultrasound (EUS) is initially performed in the-
conventional grayscale mode, with careful examinations of the
head, body, and tail of the pancreas, accomplished with the
transducer inserted in the duodenum or stomach. Color and
power Doppler examinations may be performed to visualize
the tumor and nearby blood vessels, in order to precisely de-
pict staging and determine resectability. A stable image fo-
cused on the desired area should be selected, preferably with
the tumor in the visual ﬁeld as well as one of the major blood
vessels. For low mechanical index (low-MI) examinations, the
ultrasound system software should be set up in a CHI mode,
usually with an alternate setting, with the contrast image in
the left pane and a grayscale image in the right pane. Based on
selection of a low MI (usually below 0.2) and careful selection
of the gain, a second-generation microbubble contrast agent is
injected as an intravenous bolus, and the image is recorded for
later analysis. After recording of the early arterial and late
venous phase for approximately 120 s, the system can be
changed back to the usual EUS examination mode, and color
Doppler and power Doppler can be used for a high-MI
examination, with contrast enhancement. Three-dimensional
acquisition modes can also be used in the late venous phase,
with either high MI or low MI modes.
Background and Endoscopic Ultrasound Procedures
All cross-sectional techniques (ultrasound, computed tomo-
graphy, and magnetic resonance) beneﬁt from the use of vascular
contrast agents, as they allow the visualization of parenchymal
microvasculature and perfusion, thus improving the character-
ization and differentiation of focal masses. Contrast enhance-
ment is important, especially in the pancreas, for the accurate
staging of tumors and guidance of therapeutic procedures.1
The technique of contrast-enhanced EUS (CE-EUS) is based
on the administration of a microbubble ultrasound contrast
agent (UCA) via a peripheral vein, which passes through the
lung circulation and induces contrast enhancement of the
vascular system, based on oscillations of the microbubbles
within the ultrasound ﬁeld. There are two types of examin-
ations based on a low MI used in conjunction with speciﬁc
CHI (wide-band) modes, or high MI based on Doppler
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enhancement induced by the contrast agent.2 The former
technique is preferred, as the latter is prone to artifacts caused
by high levels of the Doppler signal induced by contrast en-
hancement (blooming) or tissue motion (ﬂash). CHI EUS
procedures start by usual examinations of the focal pancreatic
mass during endosonography. After careful stabilization of the
image, the system software is switched to a low MI contrast-
speciﬁc mode and Sono-Vue is then injected (2.4–4.8 ml)
through a peripheral vein. Two phases were described already
for pancreatic imaging: an early (arterial) phase (starting from
approximately 10 s to 30 s) and a venous (late) phase (starting
from approximately 30 s to 120 s).3 After the bolus injection of
a microbubble UCA, time-intensity curves (TICs) analysis is
used as a quantitative analysis of perfusion imaging, during the
early (wash-in) and late (wash-out).
Based on the published studies, pancreatic adenocarci-
noma is hypovascular as compared to the surrounding par-
enchyma, yielding a high sensitivity, speciﬁcity, and accuracy
for the differential diagnosis of focal pancreatic masses.4–8
Chronic pseudotumoral pancreatitis has a variable appear-
ance, being usually isovascular or hypervascular, as compared
to the surrounding parenchyma.9 This latter aspect has also
been shown in autoimmune pancreatitis, which can be thus
differentiated from pancreatic adenocarcinoma.10 Pancreatic
neuroendocrine tumors have been sucessfully visualized by
CE-EUS with a better sensitivity in comparison with multi-
detector computer tomography (CT), showing mostly contrast
enhancement with or without ﬁlling defects, regardless of their
benign or malignant nature.11 The value of CE-EUS for the
differential diagnosis of focal pancreatic masses was recently
conﬁrmed by a meta-analysis that provided a high sensitivity
(94%) and speciﬁcity (89%), with an area under the curve for
the receiver operating characteristic of 0.9732.12
New techniques based on CE-EUS include 3D techniques,
performed during either high- or low-MI examinations. This
allows a thorough examination of the spatial relations of
examined lesions, in an attempt to improve staging and
evaluate resectability.13 In conclusion, CE-EUS is an important
technique for improved detection and characterization of pan-
creatic diseases, possibly in conjunction with real-time elasto-
graphy or fusion imaging with other cross-sectional techniques
such as CE-CT or -magnetic resonance (MR).14 Furthermore, the
technique might be especially useful for staging and follow-up
of advanced tumors during chemotherapy and/or anti-
angiogenic therapy.15
Key Learning Points/Tips and Tricks
– CE-EUS is helpful for the differential diagnosis of focal
pancreatic masses, improved staging of digestive cancers,
and possibly guidance of therapy.
– Image quality is highly dependent on technical details,
especially the MI, which should be set between 0.1 and 0.2.
– The low MI technique is devoid of moving artifacts, but the
image should be kept stable if quantitative (TIC) analysis
will be performed.
– Three-dimensional techniques can be used in conjunction
with both high and low MI CE-EUS, although the future
impact of such techniques for improved staging and follow-
up of treatment should be established by future studies.
Complications
Except for the complications of EUS, only a few others are re-
ported, mainly the same as in all other advanced endoscopy
procedures. Complications induced by administration of sec-
ond-generation contrast agents are very rare and include allergic
and hypersensitivity reactions, with a much lower
incidence as compared to current CT or MR contrast agents. Life-
threatening anaphylactic reactions are quite rare, being reported
in less than 0.001% of all cases.3 Moreover, UCAs are non-
nephrotoxic and do not interact with the thyroid gland, al-
though in some countries they are not licensed in pregnancy
and breastfeeding. Also, a few fatal events were described in
patients with severe cardiopulmonary disease, so caution should
be exercised in patients with severe coronary artery disease.
Alternatives
Other cross-sectional imaging techniques (CE-CT and -MR)
yield complementary information, as the UCAs are constrained
to the blood pool and do not leave the vascular space (in
contrast with CT or MR contrast agents, which yield
different and usually complementary images). Also, the
resolution of EUS is higher, even when compared with state-of-
the-art CT or MR scanners. A 3D-EUS investigation adds even
more data, as the acquired volume can be compared and
visualized by different operators, possibly decreasing operator
dependence. Nevertheless, the technique does not replace EUS-
FNA cytology and/or microhistology for conﬁrmation of the
ﬁnal diagnosis, being extremely useful for improved detection,
characterization, staging, and follow-up of pancreatic tumors.
Scripted Voiceover
Time (min:sec) Voiceover text
Case 1 – Pancreatic Adenocarcinoma
0:05 PAC gray scale 01 A hypoechoic, inhomogenous mass with
calciﬁcations, is visualized from the
stomach.
0:15 PAC Doppler 01 Doppler color ﬂow imaging clearly shows
the close contact between the
pancreatic mass and the splenic artery.
0:25 PAC lowMI Contrast harmonic imaging shows the
pancreatic mass, which is
hypoenhanced as compared with the
surrounding pancreatic parenchyma.
The splenic artery can be visualized in
the vicinity of the tumor mass.
0:45 PAC highMI Doppler color ﬂow imaging after
contrast-enhancement does not show
any signals inside the mass.
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0:50 PAC FNA procore Endoscopic ultrasound-guided ﬁne
needle aspiration was further
performed with a 19 G histological
(procore) needle.
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